Literature DB >> 24433864

The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q--new prognostic markers are needed.

Andrea Kuendgen1.   

Abstract

Entities:  

Keywords:  5q− syndrome; Deletion 5q; Lenalidomide; Myelodysplastic syndrome; Prognostic markers; Transfusion dependency

Mesh：

Substances：

Year:  2013        PMID： 24433864     DOI： 10.1016/j.leukres.2013.12.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  [Clinical analyses of 50 cases of myelodysplastic syndrome with deletion of chromosome 5q].

Authors:  Y He; X Du; J Y Weng; C X Deng; S X Geng; Z S Lu; M M Li; P J Liao; C W Luo; S J Wu; L Y Zhong
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.